Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3. (Q42213984)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 June 2014

Language	Label	Description	Also known as
English	Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.	scientific article published on 26 June 2014

Statements

scholarly article

1 reference

Europe PubMed Central

18 October 2017

Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3. (English)

1 reference

Europe PubMed Central

18 October 2017

0 references

insulin resistance

1 reference

based on heuristic

inferred from title

Mattias Mandorfer

1

1 reference

Europe PubMed Central

18 October 2017

Katharina Grabmeier-Pfistershammer

10

object named as

Katharina Grabmeier-Pfistershammer

1 reference

Europe PubMed Central

18 October 2017

Markus Peck-Radosavljevic

12

object named as

Markus Peck-Radosavljevic

0 references

Thomas Reiberger

object named as

Thomas Reiberger

13

0 references

Michael Trauner

11

object named as

Michael Trauner

1 reference

Europe PubMed Central

18 October 2017

Arnulf Ferlitsch

5

object named as

Arnulf Ferlitsch

1 reference

Europe PubMed Central

18 October 2017

Maximilian Aichelburg

6

object named as

Maximilian C Aichelburg

1 reference

Europe PubMed Central

18 October 2017

Albert F Stättermayer

7

object named as

Albert F Stättermayer

1 reference

Europe PubMed Central

18 October 2017

8

object named as

Peter Ferenci

1 reference

Europe PubMed Central

18 October 2017

2

object named as

Berit A Payer

1 reference

Europe PubMed Central

18 October 2017

Barbara Obermayer-Pietsch

9

object named as

Barbara Obermayer-Pietsch

1 reference

Europe PubMed Central

18 October 2017

author name string

Philipp Schwabl

3

1 reference

Europe PubMed Central

18 October 2017

Sebastian Steiner

4

1 reference

Europe PubMed Central

18 October 2017

publication date

26 June 2014

1 reference

Europe PubMed Central

18 October 2017

Liver International

1 reference

Europe PubMed Central

18 October 2017

35

1 reference

Europe PubMed Central

18 October 2017

3

1 reference

Europe PubMed Central

18 October 2017

876-885

1 reference

Europe PubMed Central

18 October 2017

Epidemiology of viral hepatitis and HIV co-infection

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Natural history and predictors of disease severity in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

HCV infection and metabolic syndrome: which is the chicken and which is the egg?

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Impact of vitamin D insufficiency on insulin homeostasis and beta cell function in nondiabetic male HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Concomitant highly active antiretroviral therapy leads to smaller decline and faster recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

The influence of portal pressure on the discordance between absolute CD4+ cell count and CD4+ cell percentage in HIV/hepatitis C virus-coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

D-livering the message: the importance of vitamin D status in chronic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12615

21 January 2018

Identifiers

10.1111/LIV.12615

1 reference

Europe PubMed Central

18 October 2017

1 reference

Europe PubMed Central

18 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42213984&oldid=2095939955"